Farms.com Home   News

Reduced Mycoplasma Hyopneumoniae Infections Reflect Success of Mitigation and Elimination Efforts

The Swine Health Information Center suggests reductions in the numbers of cases of Mycoplasma hyopneumoniae across the United States reflect the success of mitigation and elimination efforts.Mycoplasma hyopneumoniae, a common cause of pneumonia in pigs and characterized by a persistent dry cough, impaired growth and occasional respiratory distress, is found world wide.

The Swine Health Information Center's August domestic swine disease monitoring report indicates July saw Mycoplasma hyopneumoniae fall to its lowest monthly positivity in sow farms in the United States in 13 years.SHIC Associate Director Dr. Lisa Becton suggests the drop demonstrates the success of elimination efforts.

Quote-Dr. Lisa Becton-Swine Health Information Center:

This month's report showed the lowest monthly case positivity in sows since 2012.In addition, the confirmed case tissue diagnosis within the second quarter of 2025 was also very low.A lot of the information on mycoplasma has been garnered over time and it's been very positive to see the reduction of cases across all ages.

Producers and their veterinarians have been focussed on trying to eliminate or mitigate this pathogen in all ages of pigs and so having a reduction the case positivity is some evidence that there has been a lot of success in the field with different elimination strategies and stabilization strategies within the sow herds.Again, these results do highlight success of these efforts and could lead to potential more widespread elimination in the future.

The Swine Health Information Center's August domestic and global swine disease monitoring reports are highlighted in SHIC monthly eNewsletter and can be accessed at swinehealth.org.

Click here to see more...

Trending Video

New Solution Powers Efficient Pork Growth

Video: New Solution Powers Efficient Pork Growth


Alltech has introduced Olerix, an innovative phytogenic blend created to promote growth and feed efficiency in pigs. Through a proprietary coating process, the bioactive blend of phytogenic compounds used in Olerix is designed to outlast the manufacturing process, ensuring consistent outcomes from feed to finish. The result is a high-impact efficiency solution that provides consistent support for gut health, feed efficiency, immune function and growth performance. Olerix is backed by validated trials conducted under modern pork production conditions.

“As the industry searches for technology to drive profitability forward in a more sustainable manner, we’re thrilled to join that effort with our Olerix technology,” said Mark Hulsebus, general manager for U.S. pork at Alltech. “Our work in this phytogenic space is yielding very encouraging results, and we’re excited to make this new opportunity available to pork producers focused on optimizing feed efficiency and growth rates.”

“Olerix represents the next generation of phytogenic technology — combining feed efficiency, livability and immune support into a practical commercial solution producers can implement today,” said Andy Rash, U.S. monogastric director at Alltech.